Clinical Trial Update: Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes

View source ↗

Summary

An observational safety study evaluating NovoMix 30 in adults with Type 2 diabetes; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoMix 30 (insulin aspart protamine fixed-dose combination)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED